NO20054718L - Terapeutisk og/eller preventivt middel for kroniske hudsykdommer - Google Patents

Terapeutisk og/eller preventivt middel for kroniske hudsykdommer

Info

Publication number
NO20054718L
NO20054718L NO20054718A NO20054718A NO20054718L NO 20054718 L NO20054718 L NO 20054718L NO 20054718 A NO20054718 A NO 20054718A NO 20054718 A NO20054718 A NO 20054718A NO 20054718 L NO20054718 L NO 20054718L
Authority
NO
Norway
Prior art keywords
therapeutic
skin diseases
chronic skin
preventative agent
preventative
Prior art date
Application number
NO20054718A
Other languages
English (en)
Other versions
NO20054718D0 (no
Inventor
Haruhiko Manabe
Daisuke Harada
Shigehiro Masaki
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20054718D0 publication Critical patent/NO20054718D0/no
Publication of NO20054718L publication Critical patent/NO20054718L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen tilveiebringer et terapeutisk og/eller preventivt middel mot kroniske hudsykdommer som omfatter 7-[2-(3,5-diklor-4-pyridyl)-1-oksoetyl]-4-metoksy-spiro[1,3-benzodioksol-2,1'-cyklopentan] eller et farmasøytisk akseptabelt salt derav som en aktiv ingrediens.
NO20054718A 2003-03-17 2005-10-13 Terapeutisk og/eller preventivt middel for kroniske hudsykdommer NO20054718L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003071822 2003-03-17
PCT/JP2004/003554 WO2004082683A1 (ja) 2003-03-17 2004-03-17 慢性皮膚疾患の治療および／または予防剤

Publications (2)

Publication Number Publication Date
NO20054718D0 NO20054718D0 (no) 2005-10-13
NO20054718L true NO20054718L (no) 2005-12-09

Family

ID=33027707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054718A NO20054718L (no) 2003-03-17 2005-10-13 Terapeutisk og/eller preventivt middel for kroniske hudsykdommer

Country Status (14)

Country Link
US (1) US20060173028A1 (no)
EP (1) EP1621196A4 (no)
JP (1) JPWO2004082683A1 (no)
KR (1) KR20050108402A (no)
CN (1) CN1761466A (no)
AU (1) AU2004222432A1 (no)
BR (1) BRPI0408314A (no)
CA (1) CA2519026A1 (no)
HR (1) HRP20050905A2 (no)
MX (1) MXPA05009921A (no)
NO (1) NO20054718L (no)
RU (1) RU2005131943A (no)
WO (1) WO2004082683A1 (no)
ZA (1) ZA200507497B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006098353A1 (ja) * 2005-03-15 2008-08-28 協和醗酵工業株式会社 外用剤
WO2006123726A1 (ja) * 2005-05-18 2006-11-23 Kyowa Hakko Kogyo Co., Ltd. 医薬組成物
ATE503742T1 (de) * 2006-12-22 2011-04-15 Leo Pharma As Als pde4-inhibitoren geeignete substituierte acetophenone
WO2013030789A1 (en) * 2011-08-30 2013-03-07 Ranbaxy Laboratories Limited Pharmaceutical oral solid dosage form containing a poorly water soluble pde - iv inhibitor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4172817B2 (ja) * 1995-05-19 2008-10-29 協和醗酵工業株式会社 含酸素複素環化合物
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
TW555759B (en) * 1998-06-08 2003-10-01 Darwin Discovery Ltd Heterocyclic compounds and their therapeutic use
MY123585A (en) * 2000-03-23 2006-05-31 Merck Canada Inc Tri-aryl-substituted-ethane pde4 inhibitors.
EP1405844A4 (en) * 2001-06-29 2006-09-20 Nikken Chemicals Co Ltd CYCLOALKENONDERIVAT
TWI221838B (en) * 2001-08-09 2004-10-11 Tanabe Seiyaku Co Pyrazinoisoquinoline compound or naphthalene compound
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2006098353A1 (ja) * 2005-03-15 2008-08-28 協和醗酵工業株式会社 外用剤

Also Published As

Publication number Publication date
CN1761466A (zh) 2006-04-19
ZA200507497B (en) 2007-02-28
HRP20050905A2 (hr) 2006-04-30
AU2004222432A1 (en) 2004-09-30
KR20050108402A (ko) 2005-11-16
JPWO2004082683A1 (ja) 2006-06-22
EP1621196A4 (en) 2007-03-21
MXPA05009921A (es) 2005-11-04
BRPI0408314A (pt) 2006-03-07
WO2004082683A1 (ja) 2004-09-30
US20060173028A1 (en) 2006-08-03
RU2005131943A (ru) 2006-03-20
EP1621196A1 (en) 2006-02-01
NO20054718D0 (no) 2005-10-13
CA2519026A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
FI9630U1 (fi) Järjestelmä potilaan silmän verkkokalvon hoitamiseksi laserilla
NO20050060L (no) Medikament for behandling av overaktiv blaere
NO20053126D0 (no) Kontrollsystem for medisinsk behandling.
NO20070046L (no) Nytt cykloheksanderivat, prodrug derav og salt derav, og terapeutisk middel inneholdende de samme for diabetes
DK1690550T3 (da) Terapeutisk middel til mesothelioma
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
AR049876A1 (es) Composiciones farmaceuticas para tratar enfermedades de la piel que comprenden una combinacion de epinastina y uno o mas minerales adicionales o uno o mas farmacos brutos
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
UY27455A1 (es) Derivados n-(1,4,5,6-tetrahidro-ciclopentapirazol -3-il)- sustituidos. su obtención y uso como fármacos.
AU2002226690A1 (en) Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases
ITRM20010476A0 (it) Lamine di epitelio corneale umano ricostruite e metodo per il loro ottenimento.
NO20054718L (no) Terapeutisk og/eller preventivt middel for kroniske hudsykdommer
JP2005511619A5 (no)
DK1138306T3 (da) Medicinsk eller dentalmedicinsk behandlingsstol eller en hovedstötte til en sådan behandlingsstol
AR032422A1 (es) Uso de inhibidores de il-18 para el tratamiento y/o prevencion de la enfermedad cardiaca
SE0002729D0 (sv) Novel compound form
CY1111608T1 (el) Σκευασμα φλουπιρτινης για τη θεραπεια νευροεκφυλιστικων νοσων του οπτικου συστηματος και του σακχαρωδη διαβητη
NO20054320D0 (no) Terapeutisk middel mot hemoroidesykdom
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader
ES1057646Y (es) Protesis perfeccionada para el tratamiento quirurgico de las hernias de la ingle.
ATE435853T1 (de) Prostaglandinanaloga
HRP20050497B1 (en) Use of levocetirizine for the persistent allergic rhinitis
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
ES2188232T3 (es) Uso de cetirizina para impedir la aparicion del asma.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application